RxDoctor Payments Data

David Kiener, MD

Otolaryngology/Facial Plastic Surgery · Roseville, CANPI 1770605495

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $817 of the $967 with a category attached, or 84.5%. 9 manufacturers reported payments, led by Merz North America, Inc. at 32.7% of the total. That places this record below the midpoint for otolaryngology/facial plastic surgery clinicians in CA, where the typical reported total is $1,073.

$967in general payments, 2019–2025

Across 14 payments — averaging $69.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merz North America, Inc.$316
  • Galderma Laboratories, L.p.$150
  • AbbVie$147
  • Inspire Medical Systems, Inc.$125
  • Regeneron Healthcare Solutions, Inc.$118
  • Optinose US, Inc.$47
  • plus $65 from 3 others

What the payments were for

  • Speaking & faculty fees$15016%
  • Food & beverage$81784%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$967 in reported general payments places this provider in the 45th percentile of 102 otolaryngology/facial plastic surgery providers in California.

See all otolaryngology/facial plastic surgery providers in California

Medicare billing

Part B allowed, 2024
$12,634
Medicare patients
50
Services billed
107

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diazepam12$16

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Roseville

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →